# Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/niraparib-in-patients-with-newly-diagnosed-advanced-ovarian-cancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Antonio González-Martı́n,Bhavana Pothuri,Ignace Vergote,René dePont Christensen,Whitney A. Spannuth Graybill,Mansoor R. Mirza,Colleen McCormick,Domenica Lorusso,Paul Hoskins,Gilles Freyer,Klaus Baumann,К. Jardon,Andrés Redondo,Richard G. Moore,Christof Vulsteke,Roisin E. O’Cearbhaill,Bente Lund,Floor Backes,Pilar Barretina-Ginesta,Ashley Haggerty,María Jesús Rubio-Pérez,Mark S. Shahin,Giorgia Mangili,William H. Bradley,Ilan Bruchim,Kaiming Sun,Izabela A. Malinowska,Yong Li,Divya Gupta,Bradley J. Monk |
| Citations | 2,291 |
| DOI | 10.1056/nejmoa1910962 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nejm.org/doi/pdf/10.1056/NEJMoa1910962?articleTools=true |
| OpenAlex ID | https://openalex.org/W2975141952 |
| PMID | 31562799 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Antonio González-Martı́n](https://scholariq.org/researchers/antonio-gonzalez-mart-n/)
- [Domenica Lorusso](https://scholariq.org/researchers/domenica-lorusso/)
- [Richard G. Moore](https://scholariq.org/researchers/richard-g-moore/)
- [Roisin E. O’Cearbhaill](https://scholariq.org/researchers/roisin-e-o-cearbhaill/)
- [Ignace Vergote](https://scholariq.org/researchers/ignace-vergote/)
- [Bradley J. Monk](https://scholariq.org/researchers/bradley-j-monk/)

## Paper funders

Showing 8 of 11.

- [Amgen](https://scholariq.org/funders/amgen/)
- [Bristol-Myers Squibb](https://scholariq.org/funders/bristol-myers-squibb/)
- [Eli Lilly and Company](https://scholariq.org/funders/eli-lilly-and-company/)
- [Pfizer](https://scholariq.org/funders/pfizer/)
- [AstraZeneca](https://scholariq.org/funders/astrazeneca/)
- [GlaxoSmithKline](https://scholariq.org/funders/glaxosmithkline/)
- [Roche](https://scholariq.org/funders/roche/)
- [F. Hoffmann-La Roche](https://scholariq.org/funders/f-hoffmann-la-roche/)

## Paper journal

- [New England Journal of Medicine](https://scholariq.org/journals/new-england-journal-of-medicine/)

## Paper primary topic

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)

## Paper topics

- [PARP inhibition in cancer therapy](https://scholariq.org/topics/parp-inhibition-in-cancer-therapy/)
- [Ovarian cancer diagnosis and treatment](https://scholariq.org/topics/ovarian-cancer-diagnosis-and-treatment/)
- [Protein Degradation and Inhibitors](https://scholariq.org/topics/protein-degradation-and-inhibitors/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.